CorMedix (CRMD) Equity Ratio: 2012-2025
Historic Equity Ratio for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to 0.50.
- CorMedix's Equity Ratio fell 34.16% to 0.50 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.50, marking a year-over-year decrease of 34.16%. This contributed to the annual value of 0.71 for FY2024, which is N/A change from last year.
- Per CorMedix's latest filing, its Equity Ratio stood at 0.50 for Q3 2025, which was down 42.95% from 0.87 recorded in Q2 2025.
- In the past 5 years, CorMedix's Equity Ratio registered a high of 0.95 during Q1 2021, and its lowest value of 0.50 during Q3 2025.
- In the last 3 years, CorMedix's Equity Ratio had a median value of 0.83 in 2024 and averaged 0.79.
- Per our database at Business Quant, CorMedix's Equity Ratio grew by 24.41% in 2021 and then crashed by 34.16% in 2025.
- Over the past 5 years, CorMedix's Equity Ratio (Quarterly) stood at 0.91 in 2021, then declined by 2.56% to 0.89 in 2022, then grew by 0.32% to 0.91 in 2023, then decreased by 16.84% to 0.71 in 2024, then slumped by 34.16% to 0.50 in 2025.
- Its Equity Ratio stands at 0.50 for Q3 2025, versus 0.87 for Q2 2025 and 0.77 for Q1 2025.